Early contributors to the success of anti-COVID vaccines

The paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’ [1]. This short commentary highlights some early events that were to underpin the success of a new anti-COV...

Full description

Bibliographic Details
Main Author:	Brian Heap
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Medicine in Drug Discovery
Subjects:	Liposomes Drug delivery COVID-19 Bangham Gregoriadis Vaccines
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590098621000269

id	doaj-73a7b213d6b44c638b471af6c04ea7ae
record_format	Article
spelling	doaj-73a7b213d6b44c638b471af6c04ea7ae2021-09-03T04:46:51ZengElsevierMedicine in Drug Discovery2590-09862021-12-0112100105Early contributors to the success of anti-COVID vaccinesBrian Heap0St Edmund’s College, University of Cambridge, Cambridge CB3 OBN, UKThe paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’ [1]. This short commentary highlights some early events that were to underpin the success of a new anti-COVID vaccine.http://www.sciencedirect.com/science/article/pii/S2590098621000269LiposomesDrug deliveryCOVID-19BanghamGregoriadisVaccines
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Brian Heap
spellingShingle	Brian Heap Early contributors to the success of anti-COVID vaccines Medicine in Drug Discovery Liposomes Drug delivery COVID-19 Bangham Gregoriadis Vaccines
author_facet	Brian Heap
author_sort	Brian Heap
title	Early contributors to the success of anti-COVID vaccines
title_short	Early contributors to the success of anti-COVID vaccines
title_full	Early contributors to the success of anti-COVID vaccines
title_fullStr	Early contributors to the success of anti-COVID vaccines
title_full_unstemmed	Early contributors to the success of anti-COVID vaccines
title_sort	early contributors to the success of anti-covid vaccines
publisher	Elsevier
series	Medicine in Drug Discovery
issn	2590-0986
publishDate	2021-12-01
description	The paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’ [1]. This short commentary highlights some early events that were to underpin the success of a new anti-COVID vaccine.
topic	Liposomes Drug delivery COVID-19 Bangham Gregoriadis Vaccines
url	http://www.sciencedirect.com/science/article/pii/S2590098621000269
work_keys_str_mv	AT brianheap earlycontributorstothesuccessofanticovidvaccines
_version_	1717817947549859840

Early contributors to the success of anti-COVID vaccines

Similar Items